Rosacea associated with increased risk of generalized anxiety disorder: a case-control study of prevalence and risk of anxiety in patients with rosacea

被引:21
作者
Uysal, Pinar Incel [1 ,2 ]
Akdogan, Neslihan [1 ,2 ]
Hayran, Yildiz [1 ,2 ]
Oktem, Ayse [1 ,2 ]
Yalcin, Basak [1 ,2 ]
机构
[1] Ankara Numune Training & Res Hosp, Dermatol Dept, Ankara, Turkey
[2] Ankara Numune Training & Res Hosp, Ankara, Turkey
关键词
Anxiety; Anxiety disorders; Depression; Rosacea; QUALITY-OF-LIFE; STANDARD CLASSIFICATION; DEPRESSION; SEVERITY;
D O I
10.1016/j.abd.2019.03.002
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Rosacea may result in emotional distress and anxiety. However, data on the presence of generalized anxiety disorder in rosacea patients are scarce. Objective: The aim of the study was to detect the frequency and level of anxiety and depression in patients with rosacea. Methods: A total of 194 consecutive rosacea patients and 194 age- and sex-matched controls were enrolled. Severity of rosacea was assessed in patients according to the criteria of the National Rosacea Society Ethics Committee. Both patients and controls were evaluated by the Generalized Anxiety Disorder 7-item scale, and severity was measured by the Generalized Anxiety Disorder-Adult. Results: Individuals who were diagnosed with an anxiety and/or depressive disorder were more common in patient group (24.7% vs. 7.2%, p <0,01). Female patients were particularly at risk for having generalized anxiety disorder (OR = 2.8; 95% CI 1.15-7.37; p = 0.02 ). Study limitations: Single center study and limited sample size. Conclusions: Rosacea patients show greater risk of having anxiety disorders, including generalized anxiety disorder. Female patients, those with lower educational levels, those with phymatous subtype, untreated patients, and patients with prior psychiatric morbidity may be at particular risk for anxiety. It is essential to consider the psychological characteristics of patients to improve their well-being. (C) 2019 Sociedade Brasileira de Dermatologia. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:704 / 709
页数:6
相关论文
共 20 条
  • [11] Feelings of stigmatization in patients with rosacea
    Halioua, B.
    Cribier, B.
    Frey, M.
    Tan, J.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (01) : 163 - 168
  • [12] Psychosocial aspects of rosacea with a focus on anxiety and depression
    Heisig, Monika
    Reich, Adam
    [J]. CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2018, 11 : 103 - 107
  • [13] The PHQ-9 - Validity of a brief depression severity measure
    Kroenke, K
    Spitzer, RL
    Williams, JBW
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2001, 16 (09) : 606 - 613
  • [14] Löwe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093
  • [15] The psychological impact of rosacea and the influence of current management options
    Moustafa, Farah
    Lewallen, Robin S.
    Feldman, Steven R.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (05) : 973 - 980
  • [16] Psychiatry.org, 2013, SEV MEAS GEN ANX DIS
  • [17] A brief measure for assessing generalized anxiety disorder -: The GAD-7
    Spitzer, Robert L.
    Kroenke, Kurt
    Williams, Janet B. W.
    Loewe, Bernd
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (10) : 1092 - 1097
  • [18] Blushing Propensity and Psychological Distress in People with Rosacea
    Su, Daphne
    Drummond, Peter D.
    [J]. CLINICAL PSYCHOLOGY & PSYCHOTHERAPY, 2012, 19 (06) : 488 - 495
  • [19] Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea
    Wilkin, J
    Dahl, M
    Detmar, M
    Drake, L
    Feinstein, A
    Odom, R
    Powell, F
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (04) : 584 - 587
  • [20] The dermatology life quality index (DLQI) and the hospital anxiety and depression (HADS) in Chinese rosacea patients
    Wu, Yanyu
    Fu, Chaowei
    Zhang, Wei
    Li, Caixia
    Zhang, Jie
    [J]. PSYCHOLOGY HEALTH & MEDICINE, 2018, 23 (04) : 369 - 374